Table 5 Differences in breastfeeding and non-breastfeeding mothers with JIA six months postpartum
From: Breastfeeding in women with juvenile idiopathic arthritis: results from a Norwegian quality register
N | Breastfeeding N = 166 | N | Non-breastfeeding n = 71 | p-valuea | |
|---|---|---|---|---|---|
Patient background | |||||
Age (years), mean (SD) | 166 | 30.0 (4.1) | 71 | 28.8 (4.9) | 0.077 |
Age > 35 years, n (%) | 14 (8.4) | 8 (11.3) | 0.657 | ||
BMI (kg/m2), mean (SD) | 152 | 25.9 (15.3) | 63 | 25.6 (4.7) | 0.135 |
Overweight ≥ 25 mg/m2), n (%) | 58 (38.2) | 29 (46.0) | 0.614 | ||
Working full time or part time, n (%) | 164 | 14 (8.5) | 69 | 8 (11.6) | 0.629 |
Regular physical activity, n (%)b | 120 | 72 (60.0) | 46 | 29 (63.0) | 0.856 |
Cigarette/Snuff use, n (%) | 160 | 7 (4.4) | 66 | 11 (16.7) | 0.005 |
Education level, n (%)c | 162 | 70 | < 0.001 | ||
Low | 3 (1.9) | 2 (2.9) | |||
Intermediate | 26 (16.0) | 29 (41.4) | |||
High | 133 (82.1) | 39 (55.7) | |||
Disease related characteristics | |||||
CRP (mg/L), mean (SD) | 137 | 4.5 (7.4) | 53 | 5.0 (5.9) | 0.128 |
CRP value > 5 mg/L, n (%) | 30 (21.9) | 18 (34.0) | 0.126 | ||
DAS-28-CRP-3, mean (SD) | 121 | 2.7 (2.7) | 52 | 2.5 (0.9) | 0.412 |
Remission (DAS-28-CRP-3 < 2.6), n (%) | 76 (62.8) | 29 (55.8) | 0.484 | ||
Active disease (DAS-28-CRP-3 ≥ 2.6), n (%) | 45 (37.2) | 23 (44.2) | 0.484 | ||
VAS-score (mm), mean (SD) | |||||
Pain | 130 | 26.3 (23.4) | 53 | 29.9 (25.1) | 0.475 |
Fatigue | 131 | 30.5 (28.6) | 42.8 (31.6) | 0.028 | |
Total | 128 | 28.5 (25.4) | 48 55 | 29.6 (25.7) | 0.839 |
Medications | |||||
csDMARDs, n (%) | 162 | 44 (27.2) | 70 | 21 (29.6)d | 0.002 |
Hydroxychloroquine, n (%) | 9 (5.6) | 7 (10.0) | |||
Methotrexate, n (%) | 4 (2.5) | 10 (14.3) | |||
Sulfasalazine, n (%) | 31 (19.1) | 5 (7.1) | |||
bDMARDs, n (%) | 163 | 70 | 0.102 | ||
TNF inhibitor, n (%) | 71 (43.6) | 33 (47.1) | |||
IL-6 inhibitor, n (%) | 1 (0.61) | 3 (4.3) | |||
Corticosteroids, n (%) | 164 | 21 (12.8) | 70 | 10 (14.3) | 0.924 |